Next Article in Journal
Selected Abstracts Aubmitted to the 3rd International Cancer Fatigue Symposium
Previous Article in Journal
Adenocarcinoma Not Otherwise Specified on Dorsum of Tongue: Case Report and Literature Review
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 19
Issue 5
10.3747/co.19.1008
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Meeting Report

Treatment Recommendations for the Use of Bone-Targeted Agents in 2011—Report from the 6th Annual Bone and the Oncologist New Updates Meeting

by
I. Kuchuk
1,
A. Paterson
2,
E. Amir
3,
M. Clemons
1,* and
N. Bouganim
1
1
The Ottawa Hospital Cancer Centre, Division of Medical Oncology, University of Ottawa, Ottawa, ON, Canada
2
Tom Baker Cancer Centre, Department of Oncology, University of Calgary, Calgary, AB, Canada
3
Division of Hematology and Oncology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2012, 19(5), 364-370; https://doi.org/10.3747/co.19.1008
Submission received: 6 September 2012 / Revised: 10 September 2012 / Accepted: 11 September 2012 / Published: 1 October 2012

Abstract

The 6th annual Bone and the Oncologist New Updates conference was held in Ottawa, Ontario, April 14–15, 2011. This meeting traditionally focuses on innovative research into the mechanisms and consequences of treatment-induced and metastatic bone disease. This year, the multidisciplinary audience was polled to produce “treatment recommendations for the use of bone-targeted agents.” In addition, the meeting report itself outlines some of the key topics presented on adjuvant bisphosphonate use and the role of bone-targeted agents in the settings of meta-static and cancer-therapy-induced bone loss.
Keywords: cancer; bone health; bone metastases; bone-targeted agents cancer; bone health; bone metastases; bone-targeted agents

Share and Cite

MDPI and ACS Style

Kuchuk, I.; Paterson, A.; Amir, E.; Clemons, M.; Bouganim, N. Treatment Recommendations for the Use of Bone-Targeted Agents in 2011—Report from the 6th Annual Bone and the Oncologist New Updates Meeting. Curr. Oncol. 2012, 19, 364-370. https://doi.org/10.3747/co.19.1008

AMA Style

Kuchuk I, Paterson A, Amir E, Clemons M, Bouganim N. Treatment Recommendations for the Use of Bone-Targeted Agents in 2011—Report from the 6th Annual Bone and the Oncologist New Updates Meeting. Current Oncology. 2012; 19(5):364-370. https://doi.org/10.3747/co.19.1008

Chicago/Turabian Style

Kuchuk, I., A. Paterson, E. Amir, M. Clemons, and N. Bouganim. 2012. "Treatment Recommendations for the Use of Bone-Targeted Agents in 2011—Report from the 6th Annual Bone and the Oncologist New Updates Meeting" Current Oncology 19, no. 5: 364-370. https://doi.org/10.3747/co.19.1008

Article Metrics

Back to TopTop